FEATURES OF THE COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH KIDNEY DYSFUNCTION
Keywords:
cardiovascular diseases, glomerular filtration rate, chronic renal failure, chronic heart failureAbstract
Chronic heart failure (CHF) is the outcome of many cardiovascular diseases. Despite significant advances in the field of medical and surgical treatment of such patients, the prevalence of CHF not only does not decrease, but continues to increase [12], especially among elderly and senile people [2]. The prognosis for patients with severe CHF is unfavorable. According to the Framingham study, after the onset of clinical symptoms of CHF, about 80% of men and 65% of women die within 6 years [5]. With CHF IV class (according to NYHA), mortality within six months reaches 44%.
References
1. Мухин Н.А., Моисеев В.С. Кардиоренальные соотношения и риск сердечно-сосудистых заболеваний. Вестник РАМН. 2003;11:50–55. Arif Jivan, MD, PhD, Northwestern University Feinberg School of Medicine
2. Ситникова М. Ю. О взаимосвязи маркеров эндотелиальной дисфункции и почечной гемодинамики у больных сердечной недостаточностью и влияние на них длительной терапии периндоприлом. Клиническая фармакология и терапия. 2001;10 (1):49–52.
3. Ahmed A., Rich M.W., Sanders P.W. et al. Chronic Kidney Disease Associated Mortality in Diastolic Versus Systolic Heart Failure: A Propensity Matched Study. Am J Cardiol 2007;99:393–398
4. Arpegard J., Ostergren J., de al. Cyctatin C – a marker of peripheral atherosclerotic disease? // Atherosclerosis 2008;2:397-401.
5. Atar I., Kona D.,Azikel. S. et.al. Frequency of atrial fibrillation and factors related to its development in dialysis patients.// Int. J Cardiol // 2006;106(1):47-51.
6. Bongartz L.G., Cramer M.J., Doevendans P.A. et al. The severe cardiorenal syndrome: 'Guyton revised' // Eur. Heart J. – 2005. – Vol. 26, № 1. –P. 11-17.
7. Butler, J. Addressing the challenges of cardiorenal syndrome / J. Butler // Clev. Clin. J. Med. - 2006. - 73(5). - P. 485-491.
8. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin С is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-6.
9. E.Reznik, G.Gendlin, V. Volinkina, G.Storozhakov. «Calcium and phosphorus metabolism disturbances in patients with chronic heart failure: association with clinical symptomatic, renal function and prognosis» // Hypertension, Vol. 49, No 4, October 2007
10. Cowie M.R., Komajda M., Murray-Thomas T. et al. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure results of the prospective outcomes study in heart failure (POSH) // Eur. Heart J. 2006. Vol. 27 (100). P. 1216-1222.
